- Report
- May 2024
- 142 Pages
Global
From €3595EUR$4,000USD£3,121GBP
- Report
- January 2024
- 315 Pages
Global
From €3146EUR$3,500USD£2,731GBP
- Report
- January 2024
- 120 Pages
United States
€3146EUR$3,500USD£2,731GBP
- Report
- November 2023
- 190 Pages
Global
From €4449EUR$4,950USD£3,862GBP
- Report
- November 2023
- 110 Pages
Global
From €2652EUR$2,950USD£2,302GBP
- Report
- November 2023
- 107 Pages
From €2652EUR$2,950USD£2,302GBP
- Report
- November 2023
- 119 Pages
North America
From €2652EUR$2,950USD£2,302GBP
- Report
- November 2023
- 109 Pages
Middle East, Africa
From €2652EUR$2,950USD£2,302GBP
- Report
- November 2023
- 119 Pages
Asia Pacific
From €3101EUR$3,450USD£2,692GBP
- Report
- November 2023
- 122 Pages
Europe
From €3101EUR$3,450USD£2,692GBP
- Report
- November 2023
- 130 Pages
Global
From €1753EUR$1,950USD£1,522GBP
- Report
- June 2023
- 270 Pages
Global
From €2157EUR$2,400USD£1,873GBP
- Report
- March 2023
- 26 Pages
Global
€11011EUR$12,250USD£9,558GBP
- Drug Pipelines
- December 2022
- 148 Pages
Global
From €13478EUR$14,995USD£11,700GBP
- Report
- October 2021
- 180 Pages
United States
From €2247EUR$2,500USD£1,951GBP
- Report
- October 2021
- 70 Pages
United States
From €980EUR$1,090USD£850GBP
- Report
- April 2021
China
From €2337EUR$2,600USD£2,029GBP
- Report
- April 2021
- 85 Pages
United States
From €1168EUR$1,299USD£1,014GBP
- Report
- March 2019
- 80 Pages
United States
From €1160EUR$1,290USD£1,007GBP
- Report
- November 2018
- 30 Pages
China
From €1978EUR$2,200USD£1,717GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more